Doxorubicin is a form of antibiotic that healthcare professionals often use as a chemotherapy drug. People may refer to it as “red devil” chemotherapy due to its red color and potentially ...

Doxorubicin, which induces tumor cell death through effects on topoisomerase-II, is a commonly used chemotherapeutic agent but has the substantial drawback of causing cardiotoxicity. Edward T.H ...

Preoperative cisplatin alone may be as effective as cisplatin plus doxorubicin in standard-risk hepatoblastoma (a tumor involving three or fewer sectors of the liver that is associated with an alph ...

A phase 3 randomized clinical trial shows that adding docetaxel to anthracycline-based chemotherapy in breast cancer patients slightly improves disease-free survival.

For patients with metastatic or surgically unresectable leiomyosarcoma, combination therapy with doxorubicin and trabectedin is associated with improved overall and progression-free survival ...

Almost one in five survivors developed BC after 30 years of follow-up. Exposure to a cumulative doxorubicin dose of >200 mg/m 2 was associated with a 1.5-fold increased BC risk, independent of age at ...

Women treated with doxorubicin had a 40% higher risk for breast cancer, and that risk was independent of age of treatment, receipt of chest radiation, ... Lead image: E+ / Getty Images.

Doxorubicin chemotherapy is very effective in children with acute lymphoblastic leukemia (ALL) but also injures myocardial cells. Dexrazoxane, a free-radical scavenger, may protect the heart from d ...

To determine the cardioprotective effect of dexrazoxane (DZR) used in a doxorubicin-based combination therapy in advanced breast cancer. Patients and Methods Between November 1988 and January 1991, ...